Latest News & Features
Americas
The Saint Regis Mohawk Tribe, the owner of dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), has hit back at Mylan for questioning its sovereign immunity. 24 October 2017
Big Pharma
The EU General Court has affirmed a decision that a trademark application for ‘SeboCalm’ is confusingly similar to the earlier word mark ‘Sebotherm’. 23 October 2017
Americas
A San Diego-based company has announced plans to sell a generic version of Allergan’s dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), just days after four patents covering the drug were invalidated. 23 October 2017
Big Pharma
Alnylam Pharmaceuticals and The Medicines Company UK are facing a claim for declaratory relief over supplementary protection certificates requested by biotech company Silence Therapeutics. 20 October 2017
Big Pharma
Europe’s highest court has found that in parallel lawsuits dealing with an identical trademark, the first court must take priority over the second—but not in all cases. 19 October 2017
Americas
Amneal Pharmaceuticals and Impax Laboratories have agreed to merge, in a deal the companies say will create the fifth largest generics drugs business in the US. 19 October 2017
Americas
The Broad Institute of Harvard and MIT has signed a patent licensing deal with DuPont Pioneer to provide CRISPR/Cas9 technology to agricultural researchers and producers. 19 October 2017
Africa
CPA Global has found that Sanofi files the most patents covering human gene therapy and also spends the most on them overall. 18 October 2017
Americas
A US judge has said Allergan’s controversial patent licensing deal with a Native American tribe could spell the end for the inter partes review. 17 October 2017
Americas
A patent counsel at Eli Lilly discussed a recent dispute pitting Amgen against Sanofi and Regeneron, saying an appeals court ruling was convoluted. 17 October 2017